Osteogenic Potency of Nacre on Human Mesenchymal Stem Cells

Nacre seashell is a natural osteoinductive biomaterial with strong effects on osteoprogenitors, osteoblasts, and osteoclasts during bone tissue formation and morphogenesis. Although nacre has shown, in one study, to induce bridging of new bone across large non-union bone defects in 8 individual human patients, there have been no succeeding human surgical studies to confirm this outstanding potency. But the molecular mechanisms associated with nacre osteoinduction and the influence on bone marrow-derived mesenchymal stem cells (BMSC’s), skeletal stem cells or bone marrow stromal cells remain elusive. In this study we highlight the phenotypic and biochemical effects of Pinctada maxima nacre chips and the global nacre soluble protein matrix (SPM) on primary human bone marrow-derived stromal cells (hBMSCs) in vitro. In static co-culture with nacre chips, the hBMSCs secreted Alkaline phosphatase (ALP) at levels that exceeded bone morphogenetic protein (rhBMP-2) treatment. Concentrated preparation of SPM applied to Stro-1 selected hBMSC’s led to rapid ALP secretions, at concentrations exceeding the untreated controls even in osteogenic conditions. Within 21 days the same population of Stro-1 selected hBMSCs proliferated and secreted collagens I–IV, indicating the premature onset of an osteoblast phenotype. The same SPM was found to promote unselected hBMSC differentiation with osteocalcin detected at 7 days, and proliferation increased at 7 days in a dose-dependent manner. In conclusion, nacre particles and nacre SPM induced the early stages of human bone cell differentiation, indicating that they may be promising soluble factors with osteoinductive capacity in primary human bone cell progenitors such as, hBMSC’s.     

Clonal analysis of synovial fluid stem cells to characterize and identify stable mesenchymal stromal cell/mesenchymal progenitor cell phenotypes in a porcine model: a cell source with enhanced commitment to the chondrogenic lineage

Background aimsPrevious studies have demonstrated that porcine synovial membrane stem cells can adhere to a cartilage defect in vivo through the use of a tissue-engineered construct approach. To optimize this model, we wanted to compare effectiveness of tissue sources to determine whether porcine synovial fluid, synovial membrane, bone marrow and skin sources replicate our understanding of synovial fluid mesenchymal stromal cells or mesenchymal progenitor cells from humans both at the population level and the single-cell level. Synovial fluid clones were subsequently isolated and characterized to identify cells with a highly characterized optimal phenotype.MethodsThe chondrogenic, osteogenic and adipogenic potentials were assessed in vitro for skin, bone marrow, adipose, synovial fluid and synovial membrane–derived stem cells. Synovial fluid cells then underwent limiting dilution analysis to isolate single clonal populations. These clonal populations were assessed for proliferative and differentiation potential by use of standardized protocols.ResultsPorcine-derived cells demonstrated the same relationship between cell sources as that demonstrated previously for humans, suggesting that the pig may be an ideal preclinical animal model. Synovial fluid cells demonstrated the highest chondrogenic potential that was further characterized, demonstrating the existence of a unique clonal phenotype with enhanced chondrogenic potential.ConclusionsPorcine stem cells demonstrate characteristics similar to those in human-derived mesenchymal stromal cells from the same sources. Synovial fluid–derived stem cells contain an inherent phenotype that may be optimal for cartilage repair. This must be more fully investigated for future use in the in vivo tissue-engineered construct approach in this physiologically relevant preclinical porcine model.     

诱导体外培养的骨髓间充质干细胞向心肌样细胞的分化

选用Wistar大鼠分离骨髓间充质干细胞作体外培养及鉴定其表达抗原CD44、CDw90;采用10μmol／L 5-氮胞苷诱导第1代的骨髓间充质干细胞,于诱导后2、4周进行免疫细胞化学反应检测α-横纹肌肌动蛋白、肌钙蛋白T。证实体外培养的第1代骨髓间充质干细胞经5-氮胞苷诱导可分化为心肌样细胞,为指导体外诱导的心肌细胞应用于。临床提供一定的理论依据和技术手段。     

A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells

Glioblastoma multiforme (GBM) is among the most aggressive tumor types and is essentially an incurable malignancy characterized by resistance to chemo-, radio-, and immunotherapy. GBM is maintained by a hierarchical cell organization that includes stem-like, precursor, and differentiated cells. Recurrence and maintenance of the tumor is attributed to a small population of undifferentiated tumor-initiating cells, defined as glioblastoma stem-like cells (GSLCs). This cellular hierarchy offers a potential treatment to induce differentiation of GSLCs away from tumor initiation to a more benign phenotype or to a cell type more amenable to standard therapies. Bone morphogenetic proteins (BMPs), members of the TGF-β superfamily, have numerous biological activities including control of growth and differentiation. In vitro, a BMP7 variant (BMP7v) decreased primary human GSLC proliferation, endothelial cord formation, and stem cell marker expression while enhancing neuronal and astrocyte differentiation marker expression. In subcutaneous and orthotopic GSLC xenografts, which closely reproduce the human disease, BMP7v decreased tumor growth and stem cell marker expression, while enhancing astrocyte and neuronal differentiation compared with control mice. In addition, BMP7v reduced brain invasion, angiogenesis, and associated mortality in the orthotopic model. Inducing differentiation of GSLCs and inhibiting angiogenesis with BMP7v provides a potentially powerful and novel approach to the treatment of GBM.     

重组杆状病毒转导恒河猴骨髓间充质干细胞

【目的】研究重组杆状病毒(Bac-CMV-EGFP)能否能有效转导恒河猴骨髓间充质干细胞(rhesus Bone marrow-derived Mesenchymal Stem Cells,rBMSCs),及杆状病毒转导后对细胞活力,增殖及分化能力的影响。【方法】体外原代培养rBMSCs,不同剂量的杆状病毒转导3代以后的细胞,并用流式细胞仪分别检测其转导效率。在较高的杆状病毒转导效率下,检测rBMSCs细胞活力,增殖及分化能力,并与正常对照组细胞进行比较。【结果】杆状病毒在感染指数(Multiplicity Of Infection,MOI)为300v.g/cell,孵育温度为25度,孵育时间为4h的转导条件下,对rBMSCs转导效率可达80%左右。进一步检测后发现,高效转导杆状病毒后的rBMSCs的细胞活力,增殖及分化能力与未转导病毒细胞组无明显变化。【结论】重组杆状病毒可安全有效地基因修饰rBMSCs,且不影响其生物特性,为今后的体内基因治疗灵长类动物模型试验奠定了基础。     

研究报告：骨形态发生蛋白9通过p38激酶途径调控间充质干细胞C3H10T1/2成骨分化

前期研究发现骨形态发生蛋白9(bone morphogenetic protein 9,BMP9)具有较强的诱导间充质干细胞成骨分化的能力.为进一步揭示其诱导和调控间充质干细胞成骨分化的机理,利用BMP9重组腺病毒感染间充质干细胞C3H10T1/2,通过体外细胞实验和体内动物实验,初步分析BMP9是否可通过p38激酶途径调控间充质干细胞成骨分化.结果发现,BMP9可以通过促进p38激酶磷酸化而导致其活化,p38抑制剂SB203580可抑制由BMP9诱导的C3H10T1/2细胞的碱性磷酸酶(alkalinephosphatase,ALP)活性、骨桥蛋白(osteopontin,OPN)表达和钙盐沉积,而且利用抑制剂SB203580抑制p38激酶活性后,BMP9诱导的Smad经典途径的激活也相应受到抑制,RNA干扰导致p38基因沉默同样也可抑制BMP9诱导的ALP活性、OPN表达、钙盐沉积以及裸鼠皮下异位成骨.因此,BMP9可通过活化p38激酶途径调控间充质干细胞C3H10T1/2成骨分化.     

小鼠骨髓间充质干细胞通过miR-130b调控上皮钠通道的机制研究

该研究旨在探讨小鼠骨髓间充质干细胞(bone marrow mesenchymal stem cells,BMSCs)通过miR-130b对上皮钠通道(epithelial sodium channel,ENaC)的影响。将分离与培养的小鼠BMSCs接种到Transwell小室中,然后与H441细胞进行共培养。利用CCK-8试剂盒检测BMSCs对H441细胞生存能力的影响;采用Western blot技术检测BMSCs对共培养的H441细胞中γ-ENaC蛋白水平的影响;qRT-PCR技术检测与BMSCs共培养的H441细胞中miR-130b表达情况,然后将此microRNA转染到普通培养的H441细胞中,在蛋白水平进一步验证其对H441细胞中γ-ENaC的影响。实验结果表明,BMSCs能够增强H441细胞的生存能力;同时BMSCs能分别增加共培养的H441细胞中γ-ENaC的蛋白水平以及miR-130b的转录水平;Western blot实验进一步证实,miR-130b转染至H441细胞后能够增加其γ-ENaC的蛋白表达。由此我们推测,BMSCs能够增强H441细胞的生存能力并且可能通过miR-130b发挥其对γ-ENaC的蛋白水平调控作用。     

干细胞共培养技术在医学研究中的应用

细胞共培养技术是20世纪70年代后期发展起来的将不同种类、不同来源的细胞在同一个体系中进行培养、增殖的技术,该技术的诞生至今已经历了三十多年的时间,在共培养的细胞种类、共培养条件、共培养方法等方面均取得了很大的进展。其中,将骨髓间充质干细胞与其他种类细胞共培养,以诱导骨髓间充质干细胞定向分化的研究最为常见。该文对在神经、骨关节、心血管等系统疾病的替代治疗中有重要价值的共培养研究—骨髓间充质干细胞与不同种类的体细胞共培养作了重点介绍,以期为今后的工作提供借鉴和帮助。     

与损伤神经细胞共育后小胶质细胞促进骨髓间充质干细胞神经保护功能

采用原代细胞培养法培养骨髓间充质干细胞(BMMSCs),以鼠小胶质细胞瘤细胞(BV2)和鼠嗜铬细胞瘤细胞(PC12)细胞株分别代替小胶质细胞和神经细胞进行传代培养,应用转移筛网进行BV2与正常或损伤PC12的共育后,考察BV2对BMMSCs的神经保护作用的影响。结果发现小胶质细胞(BV2)与损伤PC12共育后,能促进BMMSCs的神经保护作用,后者的上清液能降低受损PC12的凋亡率(35.9±13.5)%,同对照组(95.1±26.6)%相比差异有统计学意义(P<0.05),且BMMSCs上清液中bFGF升高达到(34.0±10.0)pg/ml,同对照组(20.3±7.1)pg/ml相比二者差异有统计学意义(P<0.05)。